Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heron Therapeutics Inc (NASDAQ:HRTX)

33.54
BATS BZX Real-Time Price
As of 12:23pm ET
 +0.54 / +1.64%
Today’s Change
6.51
Today|||52-Week Range
36.81
+233.40%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close33.00
Today’s open33.00
Day’s range32.91 - 33.80
Volume119,059
Average volume (3 months)1,562,960
Market cap$1.1B
Dividend yield--
Data as of 12:08pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)+16.08%
Earnings growth (this year)+2.96%
Earnings growth (next 5 years)+44.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book14.99

Competitors

 Today’s
change
Today’s
% change
RPTPRaptor Pharmaceutica...-0.51-3.46%
RGENRepligen Corp-0.32-0.90%
MACKMerrimack Pharmaceut...+0.17+1.65%
CLLSCellectis SA-0.18-0.51%
Data as of 12:21pm ET, 08/04/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$0.00
Annual profit (last year)-$76.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts